Arctic Bioscience AS (OSL:ABS)
Norway
· Delayed Price · Currency is NOK 5.10
-1.00 (-16.39%)
Apr 1, 2025, 3:45 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 162.80 million as of April 1, 2025. Its market cap has decreased by -30.25% in one year.
Market Cap
162.80M
Enterprise Value
144.74M
Revenue
31.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.10
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 162.80M, a decrease of -75.64%. That is a compound annual growth rate of -29.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2025 | 133.45M | 187.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.27B |
| Nordhealth AS | 3.00B |
| Photocure ASA | 1.50B |
| Vistin Pharma ASA | 1.08B |
| Hofseth BioCare ASA | 1.01B |
| ArcticZymes Technologies ASA | 871.28M |
| Omda AS | 820.31M |
| Thor Medical ASA | 760.87M |